CAS: 405-51-6; 4-Fluorophenyl Acetate

上下游产品

CAS号371-41-5 4-氟苯酚 | CAS号75-36-5 乙酰氯 | CAS号108-24-7 乙酸酐 | CAS号113984-68-2 TERT-BUTYL(4-FL... | CAS号403-42-9 对氟苯乙酮 | CAS号459-60-9 4-氟苯甲醚 | CAS号459-26-7 4-氟苯乙醚 | CAS号3240-34-4 碘苯二乙酸 | CAS号1215465-48-7 (4,4'-di-tert-b... | CAS号830-03-5 4-硝基苯基乙酸酯 | CAS号364-32-9 4-氟-2,6-二硝基苯酚 | CAS号123871-59-0 2,5-Cyclohexadi... | CAS号394-32-1 5-氟-2-羟基苯乙酮 | CAS号32376-34-4 4-fluorophenola... | CAS号543-24-8 N-乙酰甘氨酸 | CAS号459-04-1 4-氟苯乙酰氯 | CAS号60-35-5 乙酰胺 | CAS号371-41-5 4-氟苯酚 | CAS号79-20-9 乙酸甲酯

4-氟苯乙醚置于三氯化铝,苯体系中,化学反应生成 4-氟苯基醋酸酯
参考文献:The Synthesis And Germicidal Properties Of Some Alkylfluorophenols
标题:The Synthesis And Germicidal Properties Of Some Alkylfluorophenols
摘要:
DOI:10.1021/ja01870A052

专利信息

专利号:CN-1237960-A
优先权日:1996-11-22
标题:N(-aryl/heteroarylacetyl)amino acid esters, pharmaceutical compositions comprising these esters, and methods of inhibiting the release and/or synthesis of amyloid beta peptide using these compounds

专利号:CN-108191651-A
优先权日:2018-02-02
标 题:Preparation method for synthesis of phenolic esters by visible light-catalyzed phenolic acylation reaction mediated by thiocarboxylic acid

专利号:CN-1238760-A
优先权日:1996-11-22
标 题:N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions containing such compounds, and methods for inhibiting release and/or synthesis of beta-amyloid peptides using such compounds

专利号:US-2003130188-A1
优先权日:1998-02-27
标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

专利号:US-2005215541-A1
优先权日:1996-12-23
标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

专利号:WO-2022262686-A1
优先权日:2021-06-13
标题 :Kras g12d inhibitors
发明人：HAN YING; LI DAPENG; WANG TONG
权利人:JINGRUI BIOPHARMA CO LTD
摘要:Disclosed are novel compounds which are KRAS G12D inhibitors, their synthesis and their use for treating diseases or conditions, such as cancer, and in particular for inhibiting the activity of KRAS G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.